Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 4/20 | 0.59 |
| ▸ | MAPT | P10636 | 4/20 | 0.59 |
| ▸ | HTT | P42858 | 4/20 | 0.59 |
| ▸ | RAB9A | P51151 | 4/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.59 |
| ▸ | AGTR1 | P30556 | 3/20 | 0.59 |
| ▸ | GPR55 | Q9Y2T6 | 3/20 | 0.59 |
| ▸ | XBP1 | P17861 | 3/20 | 0.59 |
| ▸ | MDM2 | Q00987 | 3/20 | 0.59 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.59 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.45 |
| ▸ | TERT | O14746 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29096257 | 1.00 | NPC1 (0.59) | NPC1MAPTHTTRAB9AMAPK1 | |
| SCHEMBL16639615 | 0.92 | NPC1 (0.62) | NPC1MAPTHTTRAB9AMAPK1 | |
| Chamissonolide SCHEMBL23601535 | 0.91 | NPC1 (0.52) | NPC1MAPTHTTRAB9AMAPK1 | |
| SCHEMBL16641594 | 0.90 | NPC1 (0.60) | NPC1MAPTHTTRAB9AMAPK1 | |
| SCHEMBL16644430 | 0.89 | NPC1 (0.59) | NPC1MAPTHTTRAB9AMAPK1 | |
| SCHEMBL20376172 | 0.89 | NPC1 (0.57) | NPC1MAPTHTTRAB9AMAPK1 | |
| Inuchinenolide C SCHEMBL28264096 | 0.84 | NPC1 (0.51) | NPC1MAPTHTTRAB9AMAPK1 | |
| SCHEMBL16639616 | 0.82 | NPC1 (0.50) | NPC1MAPTHTTRAB9AMAPK1 | |
| SCHEMBL20953522 | 0.76 | NPC1 (0.47) | NPC1MAPTHTTRAB9AMAPK1 | |
| Ergolide SCHEMBL28262978 | 0.75 | PTGS2 (0.67) | NPC1MAPTHTTRAB9AMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118286431-A | Application of HIF-1 inhibitor britannin in tumor stem cell elimination and tumor treatment | 山东大学 | 2024-07-05 | — | — | CN | claimed |
| US-20260026508-A1 | Seed Treatment Formulations and Methods of Use | PUNA BIO CORP (US) | 2026-01-29 | — | — | US | disclosed |
| EP-3924113-B1 | MECHANOCHEMICAL PROCESS | SMART MAT PRINTING B V (NL) | 2025-11-26 | — | — | EP | disclosed |
| EP-4554920-A1 | SEED TREATMENT FORMULATIONS AND METHODS OF USE | Puna Bio Corporation (US) | 2025-05-21 | — | — | EP | disclosed |
| US-12210567-B2 | Methods, systems, and media for determining playlist title coherence and quality | GOOGLE LLC (US) | 2025-01-28 | — | — | US | disclosed |
| CN-118286431-A | Application of HIF-1 inhibitor britannin in tumor stem cell elimination and tumor treatment | 山东大学 | 2024-07-05 | — | — | CN | disclosed |
| CN-118286431-A | Application of HIF-1 inhibitor britannin in tumor stem cell elimination and tumor treatment | 山东大学 | 2024-07-05 | — | — | CN | disclosed |
| CN-118286431-A | Application of HIF-1 inhibitor britannin in tumor stem cell elimination and tumor treatment | 山东大学 | 2024-07-05 | — | — | CN | disclosed |
| WO-2024118131-A1 | METHODS, SYSTEMS, AND MEDIA FOR DETERMINING PLAYLIST TITLE COHERENCE AND QUALITY | GOOGLE LLC (US) | 2024-06-06 | — | — | WO | disclosed |
| US-20240176816-A1 | METHODS, SYSTEMS, AND MEDIA FOR DETERMINING PLAYLIST TITLE COHERENCE AND QUALITY | GOOGLE LLC | 2024-05-30 | — | — | US | disclosed |
| CN-110678469-B | Substituted pyrimidinium compounds and derivatives for combating animal pests | 巴斯夫欧洲公司 | 2023-03-03 | — | — | CN | disclosed |
| WO-2022248842-A1 | SILVER ALLOY PRODUCTION | ARGENTIUM INTERNATIONAL LIMITED (GB) | 2022-12-01 | — | — | WO | disclosed |
| CN-115175996-A | Novel type VI CRISPR enzymes and systems | 博德研究所 | 2022-10-11 | — | — | CN | disclosed |
| CN-108348581-B | Insulin immunoglobulin fusion proteins | 斯克利普斯研究所 | 2022-07-01 | — | — | CN | disclosed |
| CN-113243374-B | Heterocyclic compounds as pesticides | 拜耳农作物科学股份公司 | 2022-04-26 | — | — | CN | disclosed |
| US-20220058504-A1 | AUTOCLASSIFICATION OF PRODUCTS USING ARTIFICIAL INTELLIGENCE | ACCENTURE GLOBAL SOLUTIONS LIMITED (IE) | 2022-02-24 | — | — | US | disclosed |
| US-10273220-B2 | Derivative of Inula lineariifolia lactone A | SHANXI ZHENDONG LEADING BIOTECHNOLOGY CO., LTD. (TW) | 2019-04-30 | — | — | US | disclosed |
| EP-3345896-A1 | DERIVATIVE OF INULA LINEARIIFOLIA LACTONE A | Shanxi Zhendong Leading Biotechnology Co., Ltd. (CN) | 2018-07-11 | — | — | EP | disclosed |
| EP-2865379-A1 | APPLICATION OF INULA LINEARIIFOLIA LACTONE A IN PREPARATION OF MEDICINE FOR TREATING MULTIPLE SCLEROSIS | SHANXI ZHENDONG PILOT BIOLOGICAL SCIENCE AND TECHNOLOGY CO., LTD. (CN) | 2015-04-29 | — | — | EP | disclosed |
| EP-2865380-A1 | APPLICATION OF INULA LINEARIIFOLIA LACTONE A IN PREPARATION OF MEDICINE FOR TREATING MYOCARDITIS | The Second Military Medical University (CN) | 2015-04-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10273220-B2 | Derivative of Inula lineariifolia lactone A | INMT, SIRT5, INPP5A | NPC1 3040/4885MAPT 836/4885HTT 3528/4885 |
| US-20260026508-A1 | Seed Treatment Formulations and Methods of Use | PGLS, GNE, GALE | NPC1 4274/4885MAPT 356/4885HTT 1116/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.